Striking Breakthrough: Targeting Fusion Protein Shows Promise in Childhood Leukemia Treatment
In a groundbreaking advance that could redefine treatment paradigms for pediatric acute myeloid leukemia (AML), scientists from St. Jude Children’s Research Hospital and the Dana-Farber...
















